Skip to content

Ginkgo Bioworks DNA Earnings yield

Earnings yield at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.8%+0.3pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
-2.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-13.6%-4.3pp
TEC
Bio-TechneTECH
1.4%-0.4pp
Azenta logo
AzentaAZTA
-17.8%-27.1pp
Regenxbio logo
RegenxbioRGNX
-67.1%+73.5pp

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

Based on trailing twelve months.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's earnings yield?
Ginkgo Bioworks (DNA) reported earnings yield of -80.2% in Q1 2026.
How has Ginkgo Bioworks's earnings yield changed year-over-year?
Ginkgo Bioworks's earnings yield increased by 43.8% year-over-year, from -142.7% to -80.2%.
What is the long-term trend for Ginkgo Bioworks's earnings yield?
Over 4 years (2021 to 2025), Ginkgo Bioworks's earnings yield has grown at a 47.4% compound annual growth rate (CAGR), from -13.2% to -62.1%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.